Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)

Pfizer

Status: Completed

Conditions: Scedosporium Infection

Treatments: Drug: Voriconazole

Study type: Observational

Funder types: Industry

Identifiers

NCT01660334

A1501077

Details and patient eligibility

About

To collect the efficacy and safety information of voriconazole related to their appropriate use in daily practice.

Enrollment: 13 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Male or Female patients who are prescribed voriconazole (VFEND) for deep mycosis on Scedosporisis.

Exclusion criteria

Subject who have been prescribed voriconazole (VFEND) for deep mycosis on Aspergillus, Candidasis,Cryptococcal infections not involving Scedosporisis.

Trial design

13 participants in 1 patient group

Voriconazole

Description:

Subjects who are treated with voriconazole

Treatment:

Drug: Voriconazole